SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+10.1%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$558M
AUM Growth
+$558M
(+14%)
Cap. Flow
+$28M
Cap. Flow
% of AUM
5.02%
Top 10 Holdings %
Top 10 Hldgs %
37.48%
Holding
150
New
25
Increased
36
Reduced
26
Closed
23
Top Buys
| 1 |
CEL
Cellcom Israel, Ltd.
CEL
|
$14.3M |
| 2 |
AGN
Allergan plc
AGN
|
$12.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$7.04M |
| 4 |
Merck
MRK
|
$6.72M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$6.38M |
Top Sells
| 1 |
Novartis
NVS
|
$16M |
| 2 |
Bristol-Myers Squibb
BMY
|
$13.8M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$3.99M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$3.63M |
Sector Composition
| 1 | Healthcare | 79.06% |
| 2 | Technology | 7.13% |
| 3 | Communication Services | 3.32% |
| 4 | Industrials | 1.33% |
| 5 | Financials | 1.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Corvus Pharmaceuticals
CRVS
$428M
| $3.53M | 0.5% | 221,430 -36,235 | -14% | -$578K |
|
|
STML
52
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.33M | 0.48% | 300,000 | – | – |
|
53
Cytokinetics
CYTK
$4.23B
| $3.31M | 0.47% | 227,990 +10,000 | +5% | +$145K |
|
54
Vertex Pharmaceuticals
VRTX
$100B
| $3.17M | 0.45% | +20,823 | New | +$3.17M |
|
55
Union Pacific
UNP
$133B
| $3.15M | 0.45% | 27,156 -15,244 | -36% | -$1.77M |
|
56
Palo Alto Networks
PANW
$127B
| $3M | 0.43% | +20,805 | New | +$3M |
|
57
SolarEdge
SEDG
$2.01B
| $2.91M | 0.42% | 102,003 -69,015 | -40% | -$1.97M |
|
58
Syndax Pharmaceuticals
SNDX
$1.41B
| $2.91M | 0.41% | 248,472 -47,838 | -16% | -$560K |
|
59
AnaptysBio
ANAB
$569M
| $2.8M | 0.4% | +80,000 | New | +$2.8M |
|
|
CASC
60
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $2.79M | 0.4% | 681,210 | – | – |
|
61
Axsome Therapeutics
AXSM
$6.05B
| $2.78M | 0.4% | 501,000 | – | – |
|
|
CMTA
62
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $2.75M | 0.39% | +163,000 | New | +$2.75M |
|
|
FSTX
63
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.69M | 0.38% | 159,417 -15,583 | -9% | -$262K |
|
|
BOLD
64
DELISTED
Audentes Therapeutics, Inc
BOLD
| $2.66M | 0.38% | 95,000 -55,000 | -37% | -$1.54M |
|
|
CTIC
65
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.66M | 0.38% | +833,633 | New | +$2.66M |
|
66
Summit Therapeutics
SMMT
$17.6B
| $2.65M | 0.38% | 212,018 +70,000 | +49% | +$876K |
|
67
Clearside Biomedical
CLSD
$28.9M
| $2.62M | 0.37% | 300,000 | – | – |
|
68
Ovid Therapeutics
OVID
$91M
| $2.62M | 0.37% | 305,674 | – | – |
|
69
ProQR Therapeutics
PRQR
$237M
| $2.57M | 0.37% | 530,000 +200,000 | +61% | +$970K |
|
70
Comcast
CMCSA
$125B
| $2.55M | 0.36% | +66,360 | New | +$2.55M |
|
|
ADMS
71
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $2.45M | 0.35% | 115,500 -80,000 | -41% | -$1.69M |
|
72
Nomad Foods
NOMD
$2.33B
| $2.43M | 0.35% | 166,662 -101,410 | -38% | -$1.48M |
|
73
Salarius Pharmaceuticals
SLRX
$2.94M
| $2.34M | 0.33% | +141,300 | New | +$2.34M |
|
74
Oracle
ORCL
$635B
| $2.29M | 0.33% | 47,250 | – | – |
|
|
ALBO
75
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $2.27M | 0.32% | 108,526 +5,000 | +5% | +$105K |
|